Stephen L Gwaltney

This inventor holds 35 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Glucokinase Activators. Top assignees: Takeda Pharmaceutical Company Limited, Takeda San Diego, Inc., Takeda California, Inc.. Active years: 2007-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen L Gwaltney. Retrieved from https://idiyas.com/inventor/stephen-l-gwaltney

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 (Patent Applications = 3)

% Patents Active = 28.6

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 2)

Average Co-Inventor Count = 6.2

ph-index = 7

Forward Citations = 183(Granted Patents)

Location History:

Escondido, CA (US) (2010 - 2013)
San Diego, CA (US) (2007 - 2015)

Company Filing History:

23 out of 1,226

Takeda Pharmaceutical Company Limited

patents

10 out of 53

Takeda San Diego, Inc.

patents

2 out of 2

Takeda California, Inc.

Takeda Pharmaceutical Company Limied

patents

where one patent can have more than one assignee

Years Active: 2007-2015

Loading Chart...

Areas of Expertise:

Glucokinase Activators

Dipeptidyl Peptidase Inhibitors

Apoptosis Signal-Regulating Kinase

Renin Inhibitors

Isoindoles

Pyrazole Compounds

Imidazopyridine Compounds

Substituted Indazoles

Fused Pyrazoles

Biochemical Modulators

Pharmaceutical Innovations

Therapeutic Agents

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9139598 - Glucokinase activators (2015-09-22),

2. 8563730 - Pyrazole and fused pyrazole glucokinase activators (2013-10-22),

3. 8530499 - Glucokinase activators (2013-09-10),

4. 8394843 - Substituted isoindoles as glucokinase activators (2013-03-12),

5. 8329900 - Dipeptidyl peptidase inhibitors (2012-12-11),

6. 8288539 - Dipeptidyl peptidase inhibitors (2012-10-16),

7. 8222411 - Dipeptidyl peptidase inhibitors (2012-07-17),

8. 8188275 - Dipeptidyl peptidase inhibitors (2012-05-29),

9. 8178555 - Apoptosis signal-regulating kinase 1 inhibitors (2012-05-15),

10. 8173663 - Dipeptidyl peptidase inhibitors (2012-05-08),

11. 8173645 - Glucokinase activators (2012-05-08),

12. 8163779 - Glucokinase activators (2012-04-24),

13. 8133898 - Renin inhibitors (2012-03-13),

14. 8124617 - Imidazopyridine compounds (2012-02-28),

15. 8093382 - Dipeptidyl peptidase inhibitors (2012-01-10),

Title: The Inventor Stephen L Gwaltney

Introduction: Stephen L Gwaltney is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Stephen L Gwaltney holds several patents in the areas of technology and healthcare, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: With a career spanning over two decades, Stephen L Gwaltney has worked on numerous projects that have revolutionized industries and improved people's lives. His dedication to innovation is evident in the impact of his inventions.

Collaborations: Throughout his career, Stephen L Gwaltney has collaborated with leading companies, research institutions, and universities to bring his ideas to life. These partnerships have been instrumental in the success of his projects.

Conclusion: Stephen L Gwaltney's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in San Diego, CA, and beyond.

Profile summary based on public USPTO records.